cisatracurium besylate

Min.Order / FOB Price:Get Latest Price

10 Gram	Negotiable

10 Gram

Negotiable

Min.Order :10 Gram
Purity: ≥98.5%
Payment Terms : L/C,D/P,T/T,Other

Keywords

cisatracurium besylate 96946-42-8 C65H82N2O18S2

Quick Details

Appearance:White powder
Application:Cisatracurium besylate is the latest generation of myorelaxant. Compared with the main clinical myorelaxant anesthetics, it has the characteristics of non-hepatic and non-renal metabolism and cardiova
PackAge:25kg/bag/drum,according to customer's requirment
ProductionCapacity:1000|Kilogram|Month
Storage:Store in a tightly closed container. Store in a dry area. Store at around 20oC.
Transportation:By air/by sea/ by express

Superiority:

Henan Wising Chem Co., Ltd is a national high-tech enterprise with a passion for selling and an emphasis on customer care.

We are committed to providing quality chemical products that help us become one of the most reputable, reliable and leading chemical products suppliers in the domestic and global markets.

We purpose to bring our value clients the best quality products, the most competitive prices, the shortest delivery and the best service.

Our customers include BASF, Bayer, Merck, AstraZeneca, Sun Pharma, Shanghai Pharmaceuticals, MSN Laboratories, Unither Pharmaceuticals, Cadila Healthcare, and Abbott, Amgen in the US.

Wising Chem is a reliable distributor in domestic and global markets, we own an excellent reserch team based on Zhengzhou University, Shanghai Medical College of Fudan University and Henan University of Animal Husbandry&Economy, we focus on Pharmaceutical intermediates, API, rare chemiclas, and fine chemicals.

Details:

Cisatracurium besylate is the latest generation of myorelaxant. Compared with the main clinical myorelaxant anesthetics, it has the characteristics of non-hepatic and non-renal metabolism and cardiovascular stability, and its myorelaxant effect is three times stronger than that of atracurium, without cardiovascular side effects. Cisatracurium is mainly used in general anesthesia and can be widely used in tracheal intubation, hepatic and renal dysfunction, cardiovascular surgery and geriatric and pediatric patients. Since it was first marketed in the UK in 1996, it has gradually replaced vecuronium bromide and atracurium as the mainstream of clinical inotropic agents abroad.

View All